Via: PR Newswire
Medicare to Cover Procedures within the TCAR Surveillance Project Sponsored by the Society for Vascular Surgery
SUNNYVALE, Calif., Sept. 15, 2016 /PRNewswire/ -- Silk Road Medical, Inc., a company dedicated to surgical and endovascular innovation to prevent the devastating burden of stroke, announced the Centers for Medicare and Medicaid Services (CMS) has extended coverage for the TransCarotid Artery Revascularization (TCAR) procedure under the existing National Coverage Determination 20.7. TCAR is eligible for coverage when patients are treated with any FDA-approved proximal embolic protection device and FDA-approved carotid artery stent system indicated for the transcarotid approach and entered into the new national TCAR Surveillance Project. The TCAR Surveillance Project is sponsored by the Society for Vascular Surgery (SVS) Patient Safety Organization (PSO) and has been deemed scientifically valid and clinically relevant by the Food and Drug Administration (FDA).
As outlined on the CMS Carotid Artery Stenting (CAS) Investigational Studies web page, this decision is effective immediately and provides coverage for TCAR procedures in hospitals participating in the Vascular Quality Initiative (VQI) of the SVS PSO. Reimbursement for TCAR will apply to Medicare beneficiaries who are deemed to be high risk for adverse events from traditional carotid revascularization surgery, also known as carotid endarterectomy.
Read More: http://www.prnewswire.com/news-releases/silk-road-medical-announces-new-medicare-coverage-option-for-transcarotid-artery-revascularization-tcar-procedures-300328841.html
RSS Feed
